Where should I publish my paper?
Paste your title, abstract or keywords. The finder matches them to research topics and suggests ranked journals that publish most on those topics.
Journals for “Dementia and Cognitive Impairment Research”
Suggested journals
Topic match is relative to the best match in this search (100% = best). Fees are shown only where DOAJ records them.
| # | Journal | Topic match | ITS Journal Score | Global rank | Papers 2021–2025 | Open access | Fee (APC) |
|---|---|---|---|---|---|---|---|
| 1 | Alzheimer Disease & Associated Disorders Lippincott Williams & Wilkins · United States | 100% | 67.6 | #8,234 | 285 | 51% | Not recorded |
| 2 | Dementia and Geriatric Cognitive Disorders Karger Publishers · Switzerland | 95% | 72.4 | #5,448 | 293 | 49% | Not recorded |
| 3 | American Journal of Alzheimer s Disease & Other Dementias® SAGE Publishing · United Kingdom · DOAJ | 86% | 67.0 | #8,574 | 146 | 100% | Not recorded |
| 4 | Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring Elsevier BV · United States · DOAJ | 73% | 73.5 | #4,886 | 738 | 100% | US$2,670 |
| 5 | International Journal of Geriatric Psychiatry Wiley · United Kingdom | 70% | 78.7 | #2,630 | 909 | 63% | Not recorded |
| 6 | Alzheimer s & Dementia Translational Research & Clinical Interventions Elsevier BV · United States · DOAJ | 68% | 77.0 | #3,257 | 583 | 100% | US$2,670 |
| 7 | The Journal of Prevention of Alzheimer s Disease Springer Science+Business Media · Switzerland · DOAJ | 66% | 78.9 | #2,525 | 808 | 100% | Not recorded |
| 8 | Dementia and Geriatric Cognitive Disorders Extra Karger Publishers · Switzerland · DOAJ | 74% | 59.0 | #13,496 | 101 | 100% | 1,630 CHF |
| 9 | International Psychogeriatrics Cambridge University Press · United Kingdom · DOAJ | 64% | 74.7 | #4,231 | 1,350 | 100% | US$3,500 |
| 10 | Dementia & Neuropsychologia Associação Neurologia Cognitiva e do Comportamento · Brazil · DOAJ | 69% | 66.5 | #8,895 | 349 | 100% | Not recorded |
| 11 | Alzheimer s Research & Therapy BioMed Central · United Kingdom · DOAJ | 58% | 86.5 | #616 | 1,197 | 100% | 3,490 EUR |
| 12 | Alzheimer s & Dementia Wiley · United States | 58% | 79.7 | #2,239 | 26,348 | 82% | Not recorded |
| 13 | Journal of Geriatric Psychiatry and Neurology SAGE Publishing · United States | 61% | 70.6 | #6,423 | 268 | 54% | Not recorded |
| 14 | Journal of Alzheimer s Disease Reports IOS Press · The Netherlands · DOAJ | 60% | 68.4 | #7,731 | 571 | 100% | US$2,800 |
| 15 | Psychogeriatrics Wiley · United Kingdom | 60% | 68.8 | #7,500 | 762 | 44% | Not recorded |
| 16 | Frontiers in Aging Neuroscience Frontiers Media · Switzerland · DOAJ | 51% | 84.2 | #1,007 | 4,770 | 100% | 3,150 CHF |
| 17 | Journal of Alzheimer s Disease IOS Press · The Netherlands | 52% | 81.1 | #1,817 | 4,186 | 48% | Not recorded |
| 18 | Dementia and Neurocognitive Disorders South Korea | 62% | 62.8 | #11,148 | 106 | 100% | Not recorded |
| 19 | Neurobiology of Aging Elsevier BV · United States | 52% | 81.3 | #1,731 | 1,047 | 63% | Not recorded |
| 20 | American Journal of Geriatric Psychiatry Elsevier BV · United States | 52% | 71.2 | #6,125 | 2,132 | 26% | Not recorded |
| 21 | Dementia SAGE Publishing · United Kingdom | 52% | 70.4 | #6,533 | 575 | 74% | Not recorded |
| 22 | Aging & Mental Health Routledge · United Kingdom | 42% | 75.6 | #3,834 | 1,073 | 50% | Not recorded |
| 23 | Clinical Gerontologist Taylor & Francis · United States | 40% | 69.8 | #6,871 | 425 | 49% | Not recorded |
| 24 | Journal of the International Neuropsychological Society Cambridge University Press · United Kingdom | 36% | 76.3 | #3,568 | 1,551 | 94% | Not recorded |
| 25 | Neurodegenerative Diseases Karger Publishers · Switzerland | 42% | 61.4 | #11,985 | 133 | 53% | Not recorded |
| 26 | The Lancet Neurology Elsevier BV · The Netherlands | 23% | 94.8 | #45 | 1,381 | 39% | Not recorded |
| 27 | Current Alzheimer Research Bentham Science Publishers · The Netherlands | 33% | 71.0 | #6,196 | 439 | 17% | Not recorded |
| 28 | The Clinical Neuropsychologist Taylor & Francis · United Kingdom | 30% | 74.7 | #4,283 | 522 | 39% | Not recorded |
| 29 | Applied Neuropsychology Adult Taylor & Francis · United States | 35% | 65.0 | #9,778 | 764 | 24% | Not recorded |
| 30 | The Lancet Healthy Longevity Elsevier BV · United Kingdom · DOAJ | 25% | 84.4 | #960 | 766 | 100% | US$7,860 |
Before you submit
Use this list as a shortlist, not a decision. For each journal, read its aims and scope and a few recent articles, check its peer-review and fee policy on its own website, and confirm any indexing (Scopus, Web of Science, PubMed) with the indexer itself. Be careful with journals that promise very fast acceptance or that contact you by email asking for papers.
How the ITS Journal Score works
One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.
A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.
What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.